Novel Prognostic Scores Based on Plasma Prothrombin Time and Fibrinogen Levels in Patients With AFP-Negative Hepatocellular Carcinoma
Noninvasive tools for the prognosis of α-fetoprotein negative hepatocellular carcinoma (HCC) are urgently needed. The present study proposed a prognostic system based on preoperative plasma prothrombin time and fibrinogen (PT/Fbg system). With respect to α-fetoprotein (AFP)-negative HCC, we compared...
Main Authors: | Minjie Mao MD, Xueping Wang MD, Yiling Song MD, Hui Sheng MD, Runkun Han MD, Weihong Lin MD, Shuqin Dai MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-03-01
|
Series: | Cancer Control |
Online Access: | https://doi.org/10.1177/1073274820915520 |
Similar Items
-
Diagnostic value of fibrinogen to prealbumin ratio and gamma-glutamyl transpeptidase to platelet ratio in the progression of AFP-negative hepatocellular carcinoma
by: Li Huang, et al.
Published: (2020-03-01) -
Association of Plasma Fibrinogen and Thromboelastography With Blood Loss in Complex Cardiac Surgery
by: Eline A. Vlot MD, et al.
Published: (2021-05-01) -
TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
by: Liping Mao, et al.
Published: (2017-01-01) -
Should we Test the Prothrombin Time in Anticoagulated Epistaxis Patients?
by: Michael B. Soyka M.D., et al.
Published: (2013-03-01) -
Coagulation Factor Plasma Levels Following Administration of a 4-Factor Prothrombin Complex Concentrate for Rapid Vitamin K Antagonist Reversal in Japanese Patients
by: Masahiro Yasaka, MD, et al.
Published: (2018-01-01)